What does REDEFINE-1 actually establish about survodutide?

Asked 20 Aug 2024Modified 23 months agoViewed 27k times

The specifics, since they change the answer: REDEFINE-1 · survodutide.

I want to understand what this actually establishes, as opposed to what it is being used to imply.

My concern is that I am being invited to draw a conclusion the data does not support.

What is the correct interpretation, and what is the common misreading?

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

913 questionssemaglutide

semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

360 questionscardiovascular

cardiovascular

Cardiovascular outcomes: the SELECT major-adverse-event result, SOUL, SUSTAIN 6 and REWIND, how to convert a hazard ratio into an absolute risk…

111 questions

shareeditfollowflag

askeddeamidation_watch43k3820 Aug 2024

No answers yet

This question has not been answered. It has been viewed 27k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.

Janoshik Analytical - Independent Third-Party Testing

HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.

Submit a sample

GL Biochem (Shanghai) Ltd. - Direct Synthesis

Founded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.

Visit GL Biochem

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.

Linked questions

5 What does STEP 4 actually establish about orforglipron?21 How do I convert the REDEFINE-1 hazard ratio into an absolute risk reduction?5 What does SURPASS-2 actually establish about ecnoglutide?21 How do I convert the ATTAIN-1 hazard ratio into an absolute risk reduction?

Janoshik Analytical

Independent HPLC, identity and content testing. Chromatograms included with every report.

Submit a sample

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP, batch documentation included.

Visit GL Biochem

Hot on the stack

Is resistance training seven times a week enough at 900 kcal a day?25 votes · 5 answers · 45k views What did the placebo arm of ATTAIN-1 report for dizziness?27 votes · 5 answers · 45k views Is FLOW a fair comparison of orforglipron against its comparator arm?30 votes · 5 answers · 47k views How many units on a U-100 insulin syringe is a 60 mg dose at 5 mg/mL?32 votes · 5 answers · 46k views Is 40 mg in 2 mL of 0.9% sodium chloride a sensible presentation for cagrilintide?38 votes · 3 answers · 48k views Does fatigue at week seven of liraglutide usually resolve without a dose change?17 votes · 5 answers · 47k views Would you accept 99.4% on orforglipron from SSA without a content assay?38 votes · 5 answers · 51k views

The stack

Questions5.2k

Answers20k

Accepted3.1k

Unanswered741

Tags107

Users220

Vendors tracked20